论文部分内容阅读
目的:分析在妊高征治疗中予以硫酸镁与硝苯地平控释片联合治疗的临床治疗效果及安全性。方法:选择我院收治的妊高征患者86例进行分析,选取时段为2014年8月至2016年8月期间,采用随机数字分组法进行平均分组,其中予以硫酸镁治疗的43例患者为对照组,而予以硫酸美与硝苯地平控释片联合治疗的43例患者为实验组,治疗后将2组患者的临床治疗效果进行比较和分析。结果:相较于对照组,实验组患者的治疗总有效率明显较高,2组对比差异P<0.05,形成了统计学意义;而2组患者的不良反应发生率对比差异则P>0.05,未形成统计学意义。结论:在妊高征治疗中予以硫酸镁与硝苯地平控释片联合治疗效果确切,且有较高的安全性,在临床上值得应用和推广。
Objective: To analyze the clinical efficacy and safety of combination therapy of magnesium sulfate and nifedipine in the treatment of pregnancy-induced hypertension. Methods: Eighty-six patients with PIH were enrolled in this study. The selection period was from August 2014 to August 2016. The random number grouping method was used to divide the patients into groups. Among the 43 patients treated with magnesium sulfate, The 43 patients treated with combination of sulfate and nifedipine were the experimental group. After treatment, the clinical effects of the two groups were compared and analyzed. Results: Compared with the control group, the total effective rate of the experimental group was significantly higher than that of the control group (P <0.05), and the difference was statistically significant (P <0.05) Not formed statistical significance. Conclusion: The combined treatment of magnesium sulfate and nifedipine in the treatment of PIH is effective and safe. It is worth to be applied and popularized clinically.